Paper · 40548271
Retroauricular subperiosteal vs systemic intravenous glucocorticoid administration on efficacy and blood glucose in diabetic patients with sudden deafness.
Long J and 1 other. World J Diabetes, 2025. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Retroauricular subperiosteal vs systemic intravenous glucocorticoid administration on efficacy and blood glucose in diabetic patients with sudden deafness. Papers, record 40548271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40548271
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Retroauricular subperiosteal vs systemic intravenous glucocorticoid administration on efficacy and blood glucose in diabetic patients with sudden deafness.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38,587,568 | Reactivation of hepatitis C virus caused by steroid monotherapy for sudden deafness. | Clin J Gastroenterol | 2024 | https://conductscience.org/library/papers/38587568 | PubMed |
| 2 | 36,809,749 | The Relationship between the Characteristics of Tinnitus and the Hearing Curative Effect of Sudden Deafness. | Audiol Neurootol | 2023 | https://conductscience.org/library/papers/36809749 | PubMed |
| 3 | 35,302,214 | Is sudden deafness in non-diabetic patients affected by their glycosylated hemoglobin levels? | Eur Rev Med Pharmacol Sci | 2022 | https://conductscience.org/library/papers/35302214 | PubMed |
| 4 | 37,039,340 | Local vs Systemic Use of Steroids for Sudden Deafness with Diabetes: A Systematic Review and Meta-Analysis. | Ear Nose Throat J | 2025 | https://conductscience.org/library/papers/37039340 | PubMed |
| 5 | 30,762,471 | Efficacy of combination therapy in adolescent and adult patients with total-deafness sudden sensorineural hearing loss. | Acta Otolaryngol | 2019 | https://conductscience.org/library/papers/30762471 | PubMed |
| 6 | 30,550,135 | [Analysis of the treatment effects of refractory sudden total frequency deafness with steroid from different topical administration routes]. | Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | 2018 | https://conductscience.org/library/papers/30550135 | PubMed |
| 7 | 39,915,313 | 50 years of methylprednisolone application in spinal cord injury: a bibliometric analysis. | Acta Neurochir (Wien) | 2025 | https://conductscience.org/library/papers/39915313 | PubMed |
| 8 | 23,455,194 | Doxofylline and methylprednisolone sodium succinate are stable and compatible under normal injection conditions. | Pak J Pharm Sci | 2013 | https://conductscience.org/library/papers/23455194 | PubMed |
| 9 | 30,465,620 | Intratympanic methylprednisolone administration promotes the recovery of idiopathic sudden sensorineural hearing loss: a retrospective case-control study. | Acta Otolaryngol | 2018 | https://conductscience.org/library/papers/30465620 | PubMed |
| 10 | 37,090,982 | Efficacy of intratympanic or postauricular subperiosteal corticosteroid injection combined with systemic corticosteroid in the treatment of sudden sensorineural hearing loss: A prospective randomized study. | Front Neurol | 2023 | https://conductscience.org/library/papers/37090982 | PubMed |
1 to 10 of 24
See all 24 referencesCited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,979,094 | Efficacy and safety of local vs. systemic steroid therapy for patients with sudden deafness and diabetes mellitus: A systematic review and meta-analysis. | Biomed Rep | 2026 | https://conductscience.org/library/papers/42979094 | PubMed |
| 41,394,360 | Clinical efficacy of postauricular injection of Methylprednisolone in the treatment of patients with sudden deafness: A retrospective study. | Pak J Med Sci | 2025 | https://conductscience.org/library/papers/41394360 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40548271
GET https://conductscience.org/api/papers/v1/40548271/references?page=2